Vinorelbine
Navelbine (vinorelbine) is a small molecule pharmaceutical. Vinorelbine was first approved as Navelbine on 1994-12-23. It is used to treat breast neoplasms, hodgkin disease, non-small-cell lung carcinoma, and ovarian neoplasms in the USA.
Trade Name | Navelbine |
---|---|
Common Name | Vinorelbine |
Indication | breast neoplasms, hodgkin disease, non-small-cell lung carcinoma, ovarian neoplasms |
Drug Class | Vinca alkaloids |